Additionally, emerging regulators, including FUN14 domain-containing protein 1, prohibitin 2, ceramide signaling and non-coding RNAs, which fine-tune mitophagy in NAFLD are highlighted. The gene discussed is FUNDC1; the disease is metabolic dysfunction-associated steatotic liver disease.